Related Experiment Video
Updated: Jul 8, 2025

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Machine-learning-based image analysis algorithms improve interpathologist concordance when scoring PD-L1 expression
Alexander Haragan1, Piya Parashar2, Danielle Bury2
1Department of Cellular Pathology, Royal Liverpool University Hospital, Liverpool, UK alex.haragan@nhs.net.
Machine learning tools significantly improved pathologist agreement when assessing programmed death ligand 1 (PD-L1) expression in non-small-cell lung cancer (NSCLC). This enhances the reliability of PD-L1 as a biomarker for immunotherapy response.
Area of Science:
- Oncology
- Pathology
- Medical Imaging
Background:
- Programmed death ligand 1 (PD-L1) expression is a key predictive biomarker for immunotherapy in non-small-cell lung cancer (NSCLC).
- Accurate interpretation of PD-L1 expression is challenging, potentially impacting treatment decisions.
Purpose of the Study:
- To evaluate if machine-learning-based image analysis tools can enhance inter-pathologist concordance in assessing PD-L1 expression in NSCLC.
- To determine if these tools improve the consistency of classifying PD-L1 expression levels for clinical decision-making.
Main Methods:
- Five pathologists independently scored 13 NSCLC biopsies for PD-L1 (SP263 clone) expression, both with and without a machine-learning image analysis algorithm.
- Inter-pathologist concordance was measured using Fleiss' kappa and intraclass correlation coefficients.
Main Results:
- The image analysis tool significantly improved inter-pathologist concordance (Fleiss' kappa 0.886 vs 0.613; ICC 0.954 vs 0.837).
- Fewer cases were inconsistently classified into clinical categories (negative/weak/strong) when the algorithm was used (15% vs 38%).
Conclusions:
- Machine-learning image analysis tools demonstrably improve the consistency of PD-L1 expression assessment among pathologists.
- These tools hold potential for more reliable prediction of immunotherapy response in NSCLC patients.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024